Molecular and functional properties of the human alpha(1G) subunit that forms T-type calcium channels.
We describe here several novel properties of the human alpha(1G) subunit that forms T-type calcium channels. The partial intron/exon structure of the corresponding gene CACNA1G was defined and several alpha(1G) isoforms were identified, especially two isoforms that exhibit a distinct III-IV loop: alpha(1G-a) and alpha(1G-b). Northern blot and dot blot analyses indicated that alpha(1G) mRNA is predominantly expressed in the brain, especially in thalamus, cerebellum, and substantia nigra. Additional experiments have also provided evidence that alpha(1G) mRNA is expressed at a higher level during fetal life in nonneuronal tissues (i.e. kidney, heart, and lung). Functional expression in HEK 293 cells of a full-length cDNA encoding the shortest alpha(1G) isoform identified to date, alpha(1G-b), resulted in transient, low threshold activated Ca(2+) currents with the expected permeability ratio (I(Sr) > I(Ca) >/= I(Ba)) and channel conductance ( approximately 7 pS). These properties, together with slowly deactivating tail currents, are typical of those of native T-type Ca(2+) channels. This alpha(1G)-related current was inhibited by mibefradil (IC(50) = 2 microM) and weakly blocked by Ni(2+) ions (IC(50) = 148 microM) and amiloride (IC(50) > 1 mM). We showed that steady state activation and inactivation properties of this current can generate a "window current" in the range of -65 to -55 mV. Using neuronal action potential waveforms, we show that alpha(1G) channels produce a massive and sustained Ca(2+) influx due to their slow deactivation properties. These latter properties would account for the specificity of Ca(2+) influx via T-type channels that occurs in the range of physiological resting membrane potentials, differing considerably from the behavior of other Ca(2+) channels.
Monteil
A
A
IGH-CNRS UPR 1142, 141 rue de la Cardonille, F-34396 Montpellier cedex 05, France.
Chemin
J
J
Bourinet
E
E
Mennessier
G
G
Lory
P
P
Nargeot
J
J
D000584:Amiloride / Q000494:pharmacology; D000595:Amino Acid Sequence; D002118:Calcium / Q000378:metabolism; D020747:Calcium Channels, T-Type / Q000737:chemistry / Q000235:genetics; D002460:Cell Line; D003001:Cloning, Molecular; D004594:Electrophysiology; D005786:Gene Expression Regulation; D006801:Humans; D020748:Mibefradil / Q000494:pharmacology; D008969:Molecular Sequence Data; D009532:Nickel / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism; D016415:Sequence Alignment
C121855:CACNA1G protein, human; D020747:Calcium Channels, T-Type; D012333:RNA, Messenger; D020748:Mibefradil; D000584:Amiloride; D009532:Nickel; D002118:Calcium